Coronary artery disease drugs Flashcards
Goal for lipid lowering agents
Lower LDL: prevent plaque
Drug examples of lipid lowering agents
HMG-CoA reductase inhibitors (Atorvastatin)
Bile-Acid Sequestrates (Colesvelam)
Goal for nitrates: sublingual nitroglycerin
Control pain associated with ischemia
Drugs that prevent/ dissolve blood clots
Antiplatelet Therapy: ASA
Adenosine Diphosphate Receptor Antagonist: Clopidogrel (Plavix)
Drugs that reduce cardiac workload
Beta Adrenergic Blockers: Metoprolol
Ca Channel Blockers: Nifedipine
ACE Inhibitors: Captopril
Statins brand
Atorvastatin-Lipitor
Statins description
HMG-CoA reductase inhibitors
Drugs that lower lipoprotein production
Lowers LDL and total cholesterol
Increases HDL
Lower risk of heart failure, MI, and sudden death
Significant reduction in 2 weeks but effect goes away if drug is stopped
Statins MOA
Inhibits synthesis of cholesterol by blocking HMG CoA enzyme, increases LDL receptors in hepatocytes allowing for increased removal of LDL
Adverse effects of Atorvastatin (Lipitor)
Generally well tolerated
Headache, rash, memory loss, GI disturbance (usually transient)
Myopathy/ rhabdomyolysis (mild 5-10%)
Hepatotoxicity (0.5-2%)
Nursing considerations of Atorvastatin (Lipitor)
Dose should be given in the evening because of cholesterol synthesis
GI assessment
Monitor Liver and Renal Function
Observe for muscle pain (often legs)
Colesevelam (Welchol) effect
Decrease in LDL ~20% after one month
Colesevelam (Welchol) MOA
A non-absorbable resin that binds bile acid preventing reabsorption
Bile is made from _____
cholesterol
Colesevelam can be _________
Colesevelam can be used together with statins
Metoprolol (Lopressor) MOA
Blocks cardiac Beta 1 adrenergic receptors
Reduces heart rate, force of contraction, decreased renin secretion
Indications for metoprolol
Lowers blood pressure in the large veins by slowing heart rate and widening vessels
Adverse effects of metoprolol
Bradycardia, AV heart block, heart failure, arrhythmias
Nursing considerations for metoprolol
Assess HR prior to admin
Monitor HR, chest pain, BP, and palpitations
Monitor for early signs of heart failure
Withdraw medication slowly, do not abruptly discontinue
Early warning signs of heart failure
Shortness of breath after mild exertion or lying flat, edema, weight gain, coughing at night
Precautions of beta-adrenergic antagonists and epinephrine
Epinephrine activates beta 1 receptors in heart, and beta 2 receptors in lungs, if the receptors are blocked, epinephrine may not work
Precautions of beta-adrenergic antagonists and diabetes
Blocks beta 1 receptors which give early warning signs of hypoglycemia (tachycardia, tremors, perspiration)
Calcium channel blockers drug example
Verapamil (Isoptin)
Verapamil (Isoptin) MOA
Inhibits ca ion influx across cell membrane. Heart: lowers SA/AV conduction, lowers HR, lowers force of contraction.
Arteries/ arterioles: Block ca channels on vascular smooth muscle causing vasodilation (coronary and peripheral arteries/ arterioles)
Indications for verapamil (Isoptin)
Angina, hypertension, and cardiac dysrhythmias
Therapeutic effect of verapamil (Isoptin)
Vasodilation, slows ventricular rate (good for atrial arrhythmia)
Adverse effects of verapamil (Isoptin)
Constipation, dizziness, facial flushing, headache, edema to legs and feet
Captopril MOA
Block production of angiotensin II and prevent breakdown of bradykinin which results in vasodilation, lowered blood volume, lowered cardiac remodelling, can lead to K retention
Therapeutic effects of ACE inhibitors
Vasodilation, lowered blood volume, lowered cardiac remodeling
Adverse effects of ACE inhibitors
Hypotension, cough, hyperkalemia, renal failure, angioedema
Nursing considerations for ACE inhibitors
Assess BP, pulse
Assess for signs of heart failure
Monitor hydration status
Monitor blood work (K, Urea, Creatine)
Precautions for ACE inhibitors
Caution with impaired renal function, hypovolemia, drugs that increase K (K-sparing diuretics)
Nitroglycerin spray (organic nitrate) MOA
Dilates veins in body to decrease venous return and preload which decrease workload (stable angina)
Dilates coronary arteries and increases collateral blood flow to ischemia regions
Relaxes vasospasm in coronary arteries (vasospastic angina)
Adverse effects of nitroglycerin spray (organic nitrate)
Headache, hypotension, tachycardia (secondary to vasodilation)
Difference between nitroglycerin spray (organic nitrate) and isosorbide dinitrate (long-acting nitrate)
isosorbide dinitrate (long-acting nitrate) can be in pill form to last all day. Available in immediate release and sustained release options
ASA MOA
Suppresses platelet aggregation by causing irreversible inhibition of cyclooxygenase (an enzyme)
Reduces risk of arterial thrombosis
Adverse effects of ASA
Risk of GI bleed (2.7%) - PPI used if bleeding occurs, abdominal pain, dyspepsia, diarrhea, rash
Indications for ASA
Chronic stable angina, unstable angina, acute MI, primary and secondary prevention of MI
Clopidogrel (Plavix) MOA
Irreversibly blocks P2Y12ADP receptors on platelets, preventing platelet aggregation through this pathway
Clopidogrel (Plavix) indications
Prevention of stenosis of coronary stents. Secondary prevention of MI
Dalteparin (Fragmin) MOA
Enhance activity of antithrombin
As effective as UFH but can be given in fixed dose
More expensive than UFH
Can be used by out-patients (no bloodwork required)
Indications for dalteparin
USA, NSTEMI, DVT and PE prevention
Adverse effects of dalteparin (Fragmin)
Bleeding (4%), bruises, black stool, hematuria, headaches, lumbar pain, HIT
Unfractionated heparin MOA
Enhance activity of antithrombin
Cheaper to use than LMWH
Require more monitoring (including regular aPPT)
Only used in hospital setting
Indication for UFH
Acute MI, DVT, PE
Adverse effects of UFH
Bleeding (10%), bruises, black stool, hematuria, headaches, lumbar pain, HIT
Alteplase (tPA) MOA
Binds to plasminogen -> plasmin (enzyme that digest fibrin)
Most effective when given within 4-6 hours of symptom onset (max 24hrs)
Indication for alteplase (tPA)
STEMI
Absolute contraindications for alteplase (tPA)
Prior intracranial hemorrhage
Recent stroke (last 3 months)
Active internal bleeding